The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatment

Oncology Reports

Volumn 5, Issue 1, 1998, Pages 201-204

  Miyajima, Ichiro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis C; Hepatocellular carcinoma; Interferon

Indexed keywords

ALPHA INTERFERON; INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CHRONIC HEPATITIS; CLINICAL TRIAL; DEPRESSION; FEMALE; HEARING IMPAIRMENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA HEMORRHAGE; TREATMENT OUTCOME; VIRUS HEPATITIS;

EID: 0031975858     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.1.201     Document Type: Article

References (2)

1. Nishioka K, Watanabe J, Furuta S, Tanaka E, lino S, Suzuki H, Tsuji T, Yano M, Kuo G, Choo QL, Houghton M and Oda T: A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 67: 429-433, 1991.
2. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH and Alter HJ: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12: 671-675, 1990.